Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fourier is a robotics and rehabilitation technology company that began in medical rehabilitation robotics and has expanded into humanoid robots and embodied AI systems. Its portfolio includes exoskeletons, upper- and lower-limb rehabilitation systems, RehabHub solutions, and the GRx humanoid robot series. The company serves hospitals, research institutes, and other institutions globally, with a strong footprint in rehabilitation and assistive care settings. Fourier appears to be healthcare-related through its rehabilitation robotics business, but it is not a biotech or pharmaceutical drug developer. The requested name "Fourier Transform" is not the company's exact operating name; rather, the company states that "Fourier" was named after the Fourier Transform mathematical concept.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fourier Transform.